$0.557900
-0.34-37.72%
At Close: -
$0.551100
-0.0068-1.22%
After Hours: 7:59 PM EDT
15 minutes delayed
Kazia Therapeutics
KZIANASDAQ
Kazia Therapeutics (NASDAQ:KZIA) Stock, Analyst Ratings, Price Targets, Forecasts
Kazia Therapeutics Ltd has a consensus price target of $10 based on the ratings of 3 analysts. The high is $18 issued by Maxim Group on October 14, 2021. The low is $2 issued by HC Wainwright & Co. on July 12, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Maxim Group on July 12, 2024, April 11, 2023, and October 14, 2021, respectively. With an average price target of $7.33 between HC Wainwright & Co., HC Wainwright & Co., and Maxim Group, there's an implied 1230.67% upside for Kazia Therapeutics Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Maxim Group
1calculated from analyst ratings
Analyst Ratings for Kazia Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/12/2024 | Buy Now | 262.91% | HC Wainwright & Co. | Sean Lee | $2 → $2 | Reiterates | Buy → Buy | Get Alert |
| 04/11/2023 | Buy Now | 262.91% | HC Wainwright & Co. | Sean Lee | → $2 | Upgrade | Neutral → Buy | Get Alert |
| 08/02/2022 | Buy Now | — | Maxim Group | Jason McCarthy | — | Downgrade | Buy → Hold | Get Alert |
| 08/02/2022 | Buy Now | — | HC Wainwright & Co. | Sean Lee | — | Downgrade | Buy → Neutral | Get Alert |
| 10/14/2021 | Buy Now | 3166.19% | Maxim Group | Naureen Quibria | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Kazia Therapeutics (KZIA) stock?
The latest price target for Kazia Therapeutics (NASDAQ:KZIA) was reported by HC Wainwright & Co. on July 12, 2024. The analyst firm set a price target for $2.00 expecting KZIA to rise to within 12 months (a possible 262.91% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Kazia Therapeutics (KZIA)?
The latest analyst rating for Kazia Therapeutics (NASDAQ:KZIA) was provided by HC Wainwright & Co., and Kazia Therapeutics reiterated their buy rating.
When was the last upgrade for Kazia Therapeutics (KZIA)?
The last upgrade for Kazia Therapeutics Ltd happened on April 11, 2023 when HC Wainwright & Co. raised their price target to $2. HC Wainwright & Co. previously had a neutral for Kazia Therapeutics Ltd.
When was the last downgrade for Kazia Therapeutics (KZIA)?
The last downgrade for Kazia Therapeutics Ltd happened on August 2, 2022 when Maxim Group changed their price target from N/A to N/A for Kazia Therapeutics Ltd.
When is the next analyst rating going to be posted or updated for Kazia Therapeutics (KZIA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kazia Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kazia Therapeutics was filed on July 12, 2024 so you should expect the next rating to be made available sometime around July 12, 2025.
Is the Analyst Rating Kazia Therapeutics (KZIA) correct?
While ratings are subjective and will change, the latest Kazia Therapeutics (KZIA) rating was a reiterated with a price target of $2.00 to $2.00. The current price Kazia Therapeutics (KZIA) is trading at is $0.55, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.